| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/08/2008 | CA2280770C Gene therapy for alleviating erectile dysfunction |
| 07/08/2008 | CA2265917C Method for using oligonucleotides having modified cpg dinucleosides |
| 07/08/2008 | CA2132836C Immunization by inoculation of dna transcription unit |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008079783A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/03/2008 | WO2008079412A2 Methods and compositions to treat arrhythmias |
| 07/03/2008 | WO2008077311A1 Hepatopoietin and use thereof |
| 07/03/2008 | WO2008060695A9 Antiviral inhibition of casein kinase ii |
| 07/03/2008 | WO2008054612A9 Dna composition for eliciting an immune response against tumor-associated macrophages |
| 07/03/2008 | WO2008054612A2 Dna composition for eliciting an immune response against tumor-associated macrophages |
| 07/03/2008 | WO2008048685A9 Ox40 aptamers |
| 07/03/2008 | WO2008046038A9 Intranasal therapeutics for neuroprotection |
| 07/03/2008 | WO2008033304A3 Compositions for promoting non-leaky collateral vascularization |
| 07/03/2008 | WO2008021136A3 Methods and sequences to suppress primate huntington gene expression in vivo |
| 07/03/2008 | WO2008017859A3 Ligand for the g6b receptor on blood platelets |
| 07/03/2008 | US20080161424 Compositions and Methods for the Systemic Treatment of Arthritis |
| 07/03/2008 | US20080161262 Using oligonucleotide sequences specific to interleukin beta as blocking agents for treatment and prevention of juvenile idiopathic arthritis |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161255 Use of Parp Inhibitors for Prevention and Treatment of Diabetic and Insulin Resistance Complications |
| 07/03/2008 | US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160607 Dna construct encoding ce7-specific chimeric t cell receptor |
| 07/03/2008 | US20080160048 Comprising chimeric cytomegalo virus related promoter sequence and cloning site for insertion of coding sequence in operable linkage; particle mediated gene therapy and immunization |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160032 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159998 Stem cell mediated treg activation/expansion for therapeutic immune modulation |
| 07/03/2008 | US20080159997 Transplants for myocardial scars |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/03/2008 | US20080159956 diagnosing and analyzing a mammal who has a risk of developing the disease, using antibody, or fragments thereof, which has a binding site specific for integrin |
| 07/03/2008 | CA2669916A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/02/2008 | EP1939300A1 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939294A1 Recombinant constructs of borrelia burgdorferi |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1939285A1 Light activated gene transduction using ultraviolet light for cell targeted gene delivery |
| 07/02/2008 | EP1938843A1 Lipids and lipid assemblies comrising transfection enhancer elements |
| 07/02/2008 | EP1938802A1 Interfering RNAs targeting pro-inflammatory cytokines |
| 07/02/2008 | EP1937820A2 System for delivering neuronal calcium sensor-1 (ncs-1) |
| 07/02/2008 | EP1937814A2 Anti-apoptotic protein antibodies |
| 07/02/2008 | EP1937802A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
| 07/02/2008 | EP1937312A2 Chimeric oligomeric compounds for modulation of splicing |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1799833A4 Enhanced zein reduction in transgenic corn seed |
| 07/02/2008 | EP1692284B1 Anti-apoptotically active apatamers |
| 07/02/2008 | EP1601776B1 Expression vectors comprising the mcmv ie2 promoter |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
| 07/02/2008 | EP0774002B1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 07/02/2008 | EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy |
| 07/02/2008 | CN101213305A Regulated expression of transgenes in the central nervous system of mammals |
| 07/02/2008 | CN101212988A Gene therapy for neurometabolic disorders |
| 07/02/2008 | CN101212977A Glucose inducible insulin expression and methods of treating diabetes |
| 07/02/2008 | CN101210267A Application of coding multiple small fragment RNA vector in gene interference and gene activation |
| 07/02/2008 | CN101210255A Recombination ferroportin adenovirus, preparation method and application thereof |
| 07/02/2008 | CN101210248A ILTV gD glycoprotein nucleotide sequence and amino acid sequence, recombined virus bacterin thereof and application of the bacterin |
| 07/02/2008 | CN101210044A Polypeptide and application thereof |
| 07/02/2008 | CN101210037A Short interference ribonucleic acid pointed to human OPN gene for treating tumor gene |
| 07/02/2008 | CN101209351A Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex |
| 07/02/2008 | CN100398649C Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application |
| 07/02/2008 | CN100398156C Immunity regulating type DNA vaccine for preventing and treating chicken coccidiosis |
| 07/02/2008 | CN100398155C DNA vaccine for preventing haemonchus contortus disease of ruminant |
| 07/01/2008 | US7393994 Animal model for use in the diagnosis and treatment of nervous system disorders |
| 07/01/2008 | US7393951 antisense to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP); inhibitor of cancer cell growth |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393934 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393681 System and method for electroporating a sample |
| 07/01/2008 | US7393677 Avidin-pseudotyped viral vectors and their use |
| 07/01/2008 | US7393661 Nucleic acids encoding OBG3 polypeptides |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393650 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
| 07/01/2008 | US7393525 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 07/01/2008 | US7393524 Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/26/2008 | WO2008076554A2 Methods for modifying virus surfaces |
| 06/26/2008 | WO2008075796A1 Agent for promoting recovery from blood cell depletion |
| 06/26/2008 | WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy |
| 06/26/2008 | WO2008074328A2 Microrna target site blocking oligos and uses thereof |
| 06/26/2008 | WO2008074189A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 06/26/2008 | WO2008074130A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/26/2008 | WO2008054561A9 Proteins, nucleic acids encoding the same and associated methods of use |
| 06/26/2008 | WO2008054466A9 Delivery of biologically active materials using core-shell tecto (dendritic polymers) |
| 06/26/2008 | WO2008048272A9 Method of drug delivery by carbon nanotube-chitosan nanocomplexes |
| 06/26/2008 | WO2008043782A3 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 06/26/2008 | WO2008030557A9 Compositions and methods for enhancing transport through mucus |
| 06/26/2008 | WO2008011503A3 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 06/26/2008 | WO2006026570A8 Use of stem cells to generate inner ear cells |